Related Experiment Video

Updated: Jun 12, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

[Low serum fetuin A is a risk factor of coronary artery calcification in patients starting hemodialysis]

Bin Zhang1, Wei Shi, Chao-sheng He

  • 1Department of Nephrology, Guangdong General Hospital, Guangzhou 510080, China. zhangbinyes@yahoo.com.cn

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|May 27, 2010
PubMed

Insights

Reduced serum fetuin A is linked to coronary artery calcification (CAC) and cardiovascular events in new hemodialysis patients. Lower fetuin A levels indicate a higher risk for these conditions.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Context:

  • Patients initiating hemodialysis face significant cardiovascular risks.
  • Coronary artery calcification (CAC) is a prevalent complication in this population.
  • Serum fetuin A's role as a potential biomarker for cardiovascular disease in hemodialysis patients requires further investigation.

Purpose:

  • To investigate the association between serum fetuin A levels and the presence and severity of coronary artery calcification (CAC) in patients commencing hemodialysis.
  • To determine if reduced serum fetuin A is an independent predictor of CAC and subsequent cardiovascular events in this cohort.

Summary:

  • This study analyzed 29 patients starting hemodialysis, measuring serum fetuin A and other risk factors. Coronary artery calcification (CAC) was assessed using multislice spiral CT scan (MSCT).
  • Lower serum fetuin A levels were significantly associated with a higher prevalence and score of CAC.
  • Serum fetuin A and age were independently correlated with CAC, while other factors like CRP, Ca, P, iPTH, and BMI were not significant predictors. Reduced serum fetuin A also correlated with cardiovascular events.

Impact:

  • Reduced serum fetuin A may serve as a valuable predictive biomarker for coronary artery calcification (CAC) in patients undergoing hemodialysis.
  • Identifying patients with low serum fetuin A could facilitate early intervention to mitigate cardiovascular event risk.
  • This research highlights the potential of fetuin A as a therapeutic target or diagnostic marker in managing cardiovascular complications in chronic kidney disease patients.
Abstract

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...